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1 |  INTRODUCTION
Chemoreflexes play an important role in the respiratory con-
trol system by changing ventilation in response to fluctuations 
in arterial blood gases located at the bifurcation of the com-
mon carotid arteries, and the peripheral chemoreceptors (i.e., 
carotid bodies) detect changes in arterial O2 (PaO2) and CO2 
(PaCO2). The peripheral chemoreflex (PCR) increases ven-
tilation in response to rapid decreases in PaO2 (hypoxemia) 
and increases in PaCO2 (hypercapnia) in a synergistic fashion 
(Fitzgerald & Parks,  1971; Lahiri & DeLaney,  1975; López-
Barneo et al., 2016). The PCR plays a critical role in keeping 
arterial blood gases within normal ranges, particularly in the 
face of acute or chronic blood gas challenges, such as ventila-
tory acclimatization in hypobaric hypoxia (Mathew et al., 1983; 
Severinghaus et al., 1966). In other populations (e.g., chronic 
heart failure), increased PCR sensitivity may contribute to vari-
ous disease states (Trembach & Zabolotskikh, 2017). Therefore, 
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Abstract
Central and peripheral respiratory chemoreceptors are stimulated during voluntary 
breath holding due to chemostimuli (i.e., hypoxia and hypercapnia) accumulating 
at the metabolic rate. We hypothesized that voluntary breath-hold duration (BHD) 
would be (a) positively related to the initial pressure of inspired oxygen prior to breath 
holding, and (b) negatively correlated with respiratory chemoreflex responsive-
ness. In 16 healthy participants, voluntary breath holds were performed under three 
conditions: hyperoxia (following five normal tidal breaths of 100% O2), normoxia 
(breathing room air), and hypoxia (following ~30-min of 13.5%–14% inspired O2). In 
addition, the hypoxic ventilatory response (HVR) was tested and steady-state chem-
oreflex drive (SS-CD) was calculated in room air and during steady-state hypoxia. 
We found that (a) voluntary BHD was positively related to initial oxygen status in 
a dose-dependent fashion, (b) the HVR was not correlated with BHD in any oxygen 
condition, and (c) SS-CD magnitude was not correlated with BHD in normoxia or 
hypoxia. Although chemoreceptors are likely stimulated during breath holding, they 
appear to contribute less to BHD compared to other factors such as volitional drive 
or lung volume.
K E Y W O R D S
breath-hold duration, hypoxic ventilatory response, oxygen, peripheral respiratory chemoreflex, 
respiratory chemoreceptors, steady-state chemoreflex drive
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assessing PCR sensitivity may be relevant for clinical popula-
tions (e.g., sleep apnea) and healthy populations exposed to 
acute, chronic, or intermittent bouts of hypoxia (e.g., high alti-
tude trekkers, breath-hold divers).
Common methods used to indirectly assess PCR sensitiv-
ity in humans include eliciting transient, respiratory gas tests 
in order to measure the resulting ventilatory responses to as-
sess chemoreflex magnitude (e.g., Pfoh et al., 2016; 2017). 
The short temporal nature of these tests allow investigators 
to assess respiratory responses independent of cardiovascular 
responses as well as ventilatory changes elicited from central 
chemoreceptor (CCR) stimulation (Pfoh et al., 2016). The hy-
poxic ventilatory response (HVR) test is one method used to 
assess PCR sensitivity to changes in oxygen. The HVR test 
can be elicited with acute, transient reductions in the fraction 
of inspired oxygen (i.e., FIO2) during poikilo- or isocapnic 
conditions (Nielsen & Smith,  1952; Pedersen et  al.,  1999; 
Steinback et al., 2007).
However, the methodology and nature of the HVR test 
pose limitations when applied to fieldwork or a clinical set-
ting, requiring cumbersome equipment and potentially pro-
voking respiratory discomfort. Recently, Pfoh et  al.  (2017) 
proposed a new method to assess steady-state chemoreflex 
drive (SS-CD). The SS-CD provides an indirect measure-
ment of the ventilatory strategy employed from contribu-
tions of both peripheral and CCRs in the steady state, given 
the prevailing chemostimuli, including pressure of end-tidal 
(PET)CO2 (Torr) and peripheral oxygen saturation (SpO2; 
%). Calculating the SS-CD requires only steady-state mea-
sures and minimal equipment, which could provide utility in 
fieldwork or clinical studies looking to assess chemosensitiv-
ity in the context of ventilatory acclimatization (e.g., Bruce 
et al., 2018). Voluntary breath-hold duration (BHD) has also 
been explored as an alternative test for assessing peripheral 
chemoreceptor sensitivity (e.g., Feiner et al., 1995; Trembach 
& Zabolotskikh, 2017).
The act of voluntary breath holding (apnea) stimulates the 
PCR resulting from concomitant hypoxia and hypercapnia de-
veloping at the metabolic rate following the voluntary cessa-
tion of breathing. In the untrained person, BHD is determined 
by a multitude of factors including (a) initial blood gas con-
centrations (e.g., oxygen and carbon dioxide), (b) initial lung 
volume (e.g., afferent feedback from lung stretch receptors), 
(c) metabolic rate, and (d) volitional drive (Skow et al., 2015; 
see Parkes,  2006 for review). These factors are difficult to 
isolate in humans, but duration of a voluntary apnea is the 
most objective measure to use when assessing factors that 
contributed to the termination of a voluntary apnea in the 
untrained individual (i.e., break point; Lin et al., 1974). Two 
specific break points have been identified during a voluntary 
breath hold (Lin et al., 1974): the physiological and psycho-
logical break point. Physiological break point is identified as 
the onset of involuntary diaphragmatic contractions while the 
psychological break point is when volitional breath holding 
ends and breathing resumes. Physiological break point in indi-
viduals with no previous breath-hold training will most often 
resume ventilation (psychological break point) from the unfa-
miliar sensation of an involuntary diaphragmatic contraction.
Intuitively, increased PCR sensitivity would potentially 
reduce apneic durations, resulting in a negative relationship 
between chemosensitivity and BHD. In fact, carotid body re-
section (Davidson et al., 1974) and vagal and glossopharyngeal 
nerve blockade (Guz et al., 1966) have been found to prolong 
BHD. Using mathematical modeling, Goncharov et al. (2017) 
concluded that at least 70% of BHD is influenced by chemosen-
sitivity in untrained humans. The HVR test has previously been 
shown to predict BHD via multiple linear regression (when ac-
counting for lung volume), whereas the hypercapnic ventilatory 
response test (HCVR; in hyperoxia) was not a predictor of BHD 
(Feiner et  al.,  1995). However, Trembach and Zabolotskikh 
(2017) found that the duration of an end-inspiratory voluntary 
BH was strongly and negatively correlated with PCR CO2 sen-
sitivity when quantified by a single-breath CO2 test.
To what extent chemoreceptor sensitivity, when assessed via 
transient gas perturbation tests, predicts BHD in humans remains 
somewhat inconsistent in the literature, likely due to variability 
in quantifying chemoreceptor sensitivity and the constraints and 
confounds of testing neural control of breathing in vivo (Pfoh 
et al., 2016). In addition, the extent that SS-CD may be related to 
breath holding is currently unknown. We aimed to characterize 
the effects of prior oxygenation, HVR, and SS-CD magnitude 
on voluntary BHD under conditions of steady-state hypoxia 
(13.5%–14% O2), normoxia (i.e., room air), and hyperoxia (five 
consecutive breaths of 100% O2) in order to assess the role of 
peripheral respiratory chemoreceptor activation on voluntary 
BHD. We hypothesized that (a) voluntary BHD would be posi-
tively related to the initial oxygen status (i.e., hypoxia, normoxia, 
or hyperoxia) prior to breath holding; (b) HVR responsiveness 
would be negatively related to BHD in hypoxia, normoxia, and 
hyperoxia; and (c) SS-CD magnitude in both normoxia and hy-
poxia would be negatively correlated with voluntary BHD.
2 |  MATERIALS AND METHODS
2.1 | Ethical approval
This study abided by the Canadian Government Tri-Council 
policy on research ethics with human participants (TCPS2) 
and conformed with the standards set by the latest revision 
of the Declaration of Helsinki, except for registration in a 
database. Ethical approval was received in advance through 
the Mount Royal University Human Research Ethics Board 
(Protocol 2015-26a). Following recruitment, all participants 
provided voluntary, informed, and written consent to the 
study prior to the beginning of the protocol.
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2.2 | Participant recruitment and 
inclusion criteria
A total of 16 participants volunteered for the study (29.9 ± 8.0 
years; BMI 23.9  ±  3.5  kg/m2; six males), with only a sub-
set (n = 12) completing the transient HVR test (see Section 
2.4, below). Participants were all non-hypertensive with no 
reported history of neurological, cardiovascular, or respiratory 
illness and were not taking any prescription medications aside 
from hormonal birth control. Because the monthly fluctuation 
of cycling ovarian hormones (Macnutt et al., 2012) and gen-
der (Pfoh et al., 2016) have been previously shown to be not 
related to HVR magnitude, no regard was given to the posi-
tion in the ovarian cycle in the recruitment of women in this 
study. All participants were non-smokers and abstained from 
caffeine, alcohol, and exercise for at least 12 hr prior to partici-
pation. Following pre-screening and written informed consent, 
participants were familiarized with the protocol prior to instru-
mentation (Figure 1). All data were collected in a quiet and 
darkly lit laboratory during mid-day. A subset of these par-
ticipants were also recruited for a previously published study 
(Pfoh et al., 2017), and some HVR and SS-CD values are over-
lapping in both studies. However, the question of this study 
was determined a priori in advance and is independent from 
Pfoh et al. (2017), which compared various chemoreflex tests.
2.3 | Instrumentation and data collection
All data were collected using a 16-channel PowerLab system 
(Powerlab/16SP ML880; AD Instruments; ADI) and analyzed 
offline using commercially available software (LabChart Pro 
software 8). Respiratory flow was measured through the use 
of a pneumotachometer (HR 800L flow head and spirometer 
amplifier; ADI ML141). Instantaneous ventilation (V̇I, L/min) 
was determined as the product of breath-by-breath inspired vol-
ume (VTI; calculated from the integral of the flow signal) and 
respiratory rate (RR, min
−1; calculated by 60 per period of the 
flow signal). Breath-by-breath O2 and CO2 were sampled prox-
imal to the mouth and measured in percent using a combined 
CO2 and O2 gas analyzer (ADI ML206), calibrated daily. The 
pressure of end-tidal (PET)O2 and PETCO2 was calculated and 
corrected for BTPS in Torr using the daily atmospheric pressure 
(Calgary is ≈1,045 m with PATM of ≈665 mmHg). Calculating 
oxygen saturation (ScO2; (%)) was performed using the previ-
ously described equation (Severinghaus, 1979) as in previous 
studies in our laboratory (Pfoh et al., 2016, 2017) and measured 
by a peripheral pulse oximeter (SpO2, ADI ML320) placed on 
the index finger of the right hand. ScO2 and SpO2 were ob-
served at all times to ensure values never fell below 70% satura-
tion for safety. For cardiovascular variables, participants were 
instrumented for measuring heart rate (HR; ECG electrodes 
in lead II configuration using the ADI bioamp ML132) and 
beat-by-beat blood pressure (Finometer Pro, Finapres Medical 
Systems; calibrated for every subject). Instantaneous HR was 
calculated from the R–R interval (60 per period). Mean arterial 
pressure (MAP) was calculated as a mean from the raw finger 
photoplethysmography arterial pressure tracing. Participants 
kept their eyes closed throughout the protocol while listening to 
white noise via ear buds to minimize distraction, except when 
instructions on breath holding were provided.
2.4 | Hypoxic Ventilatory Response
Following 10  min of quiet sitting for baseline measure-
ments (Table 1), the HVR test was carried out (see Pfoh 
et  al.,  2016, 2017 for detailed methodology and back-
ground). The transient HVR test consisted of three con-
secutive inspired tidal breaths of 100% N2 from a 50  L 
Douglas bag. Expired gases were directed to room air once 
passing by the gas analyzer port proximal the mouthpiece 
of the participant. The transient HVR test was repeated 
five times, each separated by 1–2 min to ensure respiratory 
F I G U R E  1  Protocol schematic. Following instrumentation, participants breathed room air for 10 min. We then carried out five consecutive 
transient hypoxic ventilatory response tests (TT-HVR), comprising three consecutive normal tidal breaths of 100% N2. Following a return to 
baseline values, participants carried out two voluntary end-inspiratory breath holds (EI-BH), the first under room air conditions, and the second 
following five tidal breaths of 100% O2. Participants then breathed FIO2 0.13.5–014 (13.5%–14%) for ~30 min to each steady state, after which they 
performed a third EI-BH in hypoxic conditions
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gases (PETCO2 and PETO2) and SpO2 levels returned to 
baseline. To administer the transient test, an investigator 
manually switched the three-way valve between room air 
and the 100% N2 gas mixture while monitoring the par-
ticipants’ respiratory flow signal. Switching between the 
inspired gas mixtures was performed during expiration, 
largely without the participants’ awareness.
2.5 | Breath holding and steady-
state hypoxia
Three separate breath holds were performed following the 
HVR protocol. Participants were first coached through two, 
randomized, maximal breath-hold maneuvers initiated at the 
end of a normal inspiration: one following breathing room 
air (normoxia), and another following breathing five normal 
tidal breaths of 100% FIO2 from a 50  L Douglas bag (i.e., 
hyperoxia). For these two randomized maneuvers, breath 
holds were initiated when all variables returned to baseline 
breathing room air (~5–10 min). Following a 10-min break, 
the participant was then exposed to a FIO2 of approximately 
0.135–0.14 (13.5%–14%), equating to simulated 4,500–
5,000m of altitude. Once the participant reached steady 
state (i.e., unchanging variables; e.g., ventilation, PETCO2, 
and SpO2; ~30  min), they performed the third breath-hold 
maneuver. The initiation of each breath hold began with five 
coached breaths at their normal (i.e., resting) tidal volume to 
avoid anticipatory changes in breathing rate or tidal volume 
(leading to hypocapnia), and each breath hold was held until 
volitional break point. No practice breath holds were per-
formed, nor were participants given encouragement through-
out the breath hold. Each participant completed testing during 
a single laboratory visit (~2 hr).
2.6 | Data Analysis and Statistics
2.6.1 | Baseline Data
For all baseline measures, a mean value over 30 s (i.e., 30-s 
bin) that appeared most stable and representative for each 
participant's baseline was calculated from a 1-min section 
at least 30-s prior to the first HVR test. For cardiovascular 
variables, we quantified beat-by-beat HR (min-1) and MAP 
(mm Hg). For respiratory variables, we quantified respira-
tory rate (RR; min
−1), breath-by-breath inspired volume (VTI; 
L), inspired ventilation (Vİ, L/min; the product of breath-
by-breath VT and RR), PETCO2 and PETO2 (Torr; BTPS), 
and ScO2 (%; calculated from the equation described by 
Severinghaus, 1979). ScO2 was also used to avoid the well-
described delay in measuring peripheral pulse oximetry 
Variable






EI-BHD (s) 53.8 ± 16.2** 40.4 ± 13.8** 89.9 ± 38.2**
HR (min−1) 66.7 ± 15.3 73.1 ± 18.0* —
MAP (mm Hg) 102.1 ± 7.9 99.5 ± 7.3 —
RR (min
−1) 11.3 ± 3.3 12.6 ± 4.0 —
VTI (L) 1.03 ± 0.4 1.1 ± 0.2 —
Vİ (L/min) 10.6 ± 1.5 11.9 ± 1.9
* —
PETCO2 (Torr; BTPS) 33.6 ± 2.1 31.7 ± 1.8
* —
PETO2 (Torr; BTPS) 85.0 ± 3.6 43.3 ± 3.5
* —
ScO2 (%) 96.4 ± 0.4 78.6 ± 3.6
* —
SpO2 (%) 96.9 ± 0.9 78.4 ± 4.0
* —
SS-CD (V̇I/SI; a.u.) 30.7 ± 5.2 29.3 ± 4.3 —
HVR (∆Vİ/∆ScO2; L/min/%) 0.38 ± 0.18 — —
Note: Baseline data obtained while breathing room air and after reaching steady state while breathing 
13.5%–14% FIO2 (~30-min).
Abbreviations: and HVR, hypoxic ventilatory response (tested via 5× transient N2 test). EI-BHD, end-
inspiratory breath-hold duration; HR, heart rate; MAP, mean arterial pressure; PETCO2, partial pressure end-
tidal carbon dioxide; PETO2, partial pressure end-tidal oxygen; RR, respiratory rate; ScO2, calculated oxygen 
saturation; SpO2, peripheral oxygen saturation by pulse oximetry; SS-CD, steady-state chemoreflex drive; Vİ, 
ventilation; VTI, inspired tidal volume.
EI-BHD in hyperoxia (third column) is following five consecutive tidal breaths of 100% FIO2. Values are 
mean ± SD.
*Statistically different than room air (p < .05); 
**Statistically different than all other conditions (p < .001). 
T A B L E  1  Breath-hold duration and 
baseline variables in room air and in steady-
state normobaric hypoxia
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(Trivedi et  al.,  1997) and the known differences between 
SpO2 and ScO2 in hypoxic conditions (Pfoh & Day, 2016; 
Pfoh et  al.,  2016, 2017). We estimated V̇CO2 from Vİ and 
peak fraction of expired (FE)CO2 values in the steady state 
in both normoxia and hypoxia (Vİ × FECO2/2), corrected for 
STPD (0.813 conversion factor).
2.6.2 | Hypoxic Ventilatory Response
For each trial, ventilatory responses were calculated as a 
change in ventilation from baseline values to the peak re-
sponses (ΔV ̇I) over a change in stimulus (ΔScO2). The ΔV̇I 
was calculated as the difference (delta) between baseline V̇I 
prior to the test (15 s bin) and as the average V ̇I of the two 
largest consecutive breaths within the first 20 s following the 
stimulus, wherever it occurred, similar to previous studies 
in our laboratory (Pfoh et al., 2016; 2017). The ScO2 stimu-
lus was calculated using the visually identified PETO2 on the 
third 100% N2 breath. The average response of five trials was 
taken as the representative value for that participant.
2.6.3 | Breath Holding
Using respiratory flow in conjunction with inspired and ex-
pired volume measurements, BHD was determined using 
LabChart. Although we did not attempt to measure the physi-
ological breakpoint (e.g., respiratory effort belt), with par-
ticipants being untrained in breath holding, their final break 
point most likely represented both psychological and physi-
ological break point (Parkes, 2006).
2.6.4 | Calculating SS-CD
During baseline periods while breathing room air and dur-
ing steady-state hypoxia, a stimulus-index was calculated 
(SI; PETCO2/SpO2; Torr/%; e.g., Bruce et  al.,  2016; Pfoh 
et al., 2017) to represent the contributions from CO2 and O2 
chemostimuli acting on both central and peripheral chemo-
receptors (i.e., PETCO2 and SpO2). The SI was then indexed 
against baseline V̇I during both normoxic and hypoxic 
steady-state conditions to calculate SS-CD (Pfoh et al., 2017; 
see Table 1).
2.7 | Statistics
All values are reported in Table 1 and Results as mean ± stand-
ard deviation (SD). Statistical significance was assumed 
when p < .05 (SigmaPlot v14, Systat).
Average baseline values during room air and steady-state 
hypoxia are summarized in Table 1 for all participants. Paired 
t-tests were used to test for differences in variables between 
normoxia and hypoxia.
In order to assess the statistical relationship between 
apneic duration and initial oxygen status, a one-factor re-
peated-measures analysis of variance (ANOVA) test was 
performed (Table  1 and Figure  2a). When significant F-
ratios were detected, a Student–Newman–Keuls post hoc 
test was used for multiple pair-wise comparisons between 
the three oxygen levels (hypoxia, normoxia, and hyperoxia; 
Figure 2a).
Paired t-tests were used to compare the delta (Figure 2b) 
and percent change (Figure 2c) in BHD from normoxia be-
tween hypoxia and hyperoxia.
Pearson product moment correlation tests were used 
to assess relationships between (a) all absolute breath hold 
durations (BHD) in hypoxia, normoxia, and hyperoxia 
(Figure 3a–c) and the HVR; (b) the delta (Figure 4a,b) and 
percent change (Figure 4c,d in BHD from normoxia and the 
HVR in hypoxia (Figure 4a,c) and hyperoxia (Figure 4b,d); 
and (c) the relationship between BHD in normoxia and hy-
poxia and the respective SS-CD.
Lastly, a paired t-test was also used to compare SS-CD 
between normoxia and hyperoxia.
3 |  RESULTS
3.1 | Cardiorespiratory Variables in 
Normoxia versus Hypoxia
Table 1 presents baseline cardiorespiratory data while breathing 
room air (normoxia) and after reaching steady state (~30 min) 
while breathing steady-state hypoxia (FIO2 0.135–0.14). Of note, 
HR, V̇I, PETCO2, PETO2, ScO2, and SpO2 were all statistically 
different in hypoxia compared to normoxia. Estimated V̇CO2 
was marginally, but significantly, higher in steady-state hypoxia 
compared to room air (249.3 ± 46.5 versus 232.8 ± 32.8 ml/min, 
respectively; +7.0 ± 12.9% increase in hypoxia; p = .03).
3.2 | Normoxic, hyperoxic, and 
hypoxic BHDs
For the normoxic breath hold (i.e., breathing room air), partici-
pants held their breath, on average for 53.8 ± 16.2 s. Hyperoxic 
BHDs were longer than normoxia at 89.9 ± 38.2 s (p < .001). 
Breath holds following steady-state hypoxia were statistically 
shorter than normoxia at 40.4 ± 13.8 s (p < .001; see Figure 2a). 
In addition, compared to room air (i.e., normoxia), the steady-
state hypoxic breath hold was −13.4 ± 8.7 s (−24.5 ± 3.6%) 
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shorter, while the hyperoxic breath hold was + 36.1 ± 26.1 s 
(+65.1 ± 37.7%) longer (Figure 2b,c).
3.3 | HVR and SS-CD
Using the transient 100% N2 test, the HVR was on average 
0.38 ± 0.18 L/min/% ScO2 (n = 12; Table 1), similar to previ-
ous reports in our laboratory (Pfoh et al., 2016, 2017). SS-CD 
was not different between normoxia (30.7 ± 5.2) and hypoxia 
(29.3 ± 4.3; p = .2; n = 16; Figure 5a), similar to previous re-
ports in our laboratory (Bruce et al., 2018; Pfoh et al., 2017).
3.4 | BHD and the HVR
Both absolute (delta) and relative (% change from nor-
moxia) BHDs appeared to have no significant relation-
ship with HVR magnitude. BHD in hypoxia (Figure  3a), 
normoxia (Figure 3b), and hyperoxia (Figure 3c) was not 
related to the HVR (r < .54; p > .07, n = 12). The change 
in BHD from normoxia to hypoxia was not correlated with 
HVR (r = −.27, p =  .39, n = 12; Figure 4a), or was the 
change in BHD from normoxia to hyperoxia (r  =  0.33, 
p  =  .3 n  =  12; Figure  4b). Similarly, percent change in 
BHD from normoxia to hypoxia was not correlated with 
HVR (r = .002, p = .995, n = 12; Figure 4c), or was the per-
cent change in BHD from normoxia to hyperoxia (r = .06, 
p = .84, n = 12; Figure 4d).
3.5 | BHD and SS-CD
There were no differences in SS-CD between normoxia and 
hypoxia (p = .2; Figure 5a). Voluntary BHD was not correlated 
with SS-CD in either normoxia (r = −.05, p = .85, n = 16; 
Figure 5b) or hypoxia (r = .11, p = .69, n = 16; Figure 5c).
4 |  DISCUSSION
We aimed to assess the relationship between prior oxygena-
tion on voluntary BHD, and to assess the possible relation-
ship among BHD, HVR, and SS-CD, within individuals. The 
F I G U R E  2  Breath-hold duration (BHD) in steady-state hypoxia, normoxia, and hyperoxia. (a) Absolute BHD in steady-state hypoxia (13.5%–
14% O2; 40.4 ± 13.8 s), normoxia (room air; mean 53.8 ± 16.2 s), and hyperoxia (following five tidal breaths of inspired 100% O2; 89.9 ± 38.2 s). 
(b) Changes in BHD from normoxia in steady-state hypoxia (−13.4 ± 8.7 s) and hyperoxia (36.1 ± 26.1). (c) Percent changes in BHD from 
normoxia in steady-state hypoxia (−24.5 ± 14.5%) and hyperoxia (65.1 ± 37.7%). Each transparent circle represents one individual, and horizontal 
bars represent the mean. *Significantly different from normoxic breath hold (p < .001)
F I G U R E  3  Within-individual correlations between absolute BHD and the hypoxic ventilatory response (HVR). (a) Relationship between 
Absolute BHD in steady-state hypoxia (13.5%–14% O2) and HVR (r = .45, p = .14, n = 12). (b) Relationship between absolute BHD in normoxia 
(i.e., room air) and HVR (r = .54, p = .07, n = 12). (c) Relationship between Absolute BHD in hyperoxia (following five breaths of 100% O2) and 
HVR (r = .46, p = .13, n = 12). The respective r value (Pearson correlation coefficient), p value, and n are presented on each graph
   | 7 of 12BRUCE Et al.
principal findings of our study are as follows: (a) BHD dura-
tion was dependent on the initial fraction of inspired oxygen 
immediately before voluntary apnea, such that BHD is posi-
tively related to prior oxygenation in a dose-dependent fashion 
(i.e., shorter in hypoxia and longer in hyperoxia); (b) hypoxic, 
normoxic, and hyperoxic BHD were not related to the HVR; 
and (c) normoxic and hypoxic BHD were not correlated with 
SS-CD, which takes into account both central and peripheral 
chemoreceptor contributions to BHD in the steady state.
4.1 | BHD and Prior Oxygenation
We found that alterations in prior FIO2 affected voluntary 
BHD, indicating peripheral chemoreceptor activation (hy-
poxia; i.e., decreased duration) and inhibition/withdrawal 
(hyperoxia; increased duration) plays an important role in 
determining BHD. These results are consistent with previous 
studies, which assessed the effects of initial oxygen status on 
voluntary BHD (e.g., Engel et  al.,  1946; Ferris et al., 1946; 
Godfrey & Campbell, 1969; Klocke & Rahn, 1959). For exam-
ple, Engel et al. (1946) found inspired oxygen tensions (below 
that of sea level values) prior to initiating a breath-hold dras-
tically decreased duration, which was less pronounced when 
approached prior inspired oxygen tensions of 100%. Although 
our results do not suggest an exponential relationship per se 
between prior oxygen tension and BHD, our data still indicate 
BHD is somewhat dependant on initial inspired oxygen.
4.2 | BHD and Chemoreflex Magnitude
Breath holding is a unique stressor, eliciting incremen-
tal hypoxia, hypercapnia, and sympathetic nervous 
F I G U R E  4  Within-individual correlations between relative BHD and the hypoxic ventilatory response (HVR). (a) Relationship between delta 
BHD from normoxia in steady-state hypoxia (13.5%–14% O2) and HVR (r = −.27, p = .39, n = 12). (b) Relationship between delta BHD from 
normoxia in hyperoxia (following five breaths of 100% O2) and HVR (r = .33, p = .3, n = 12). (c) Relationship between percent change in BHD 
from normoxia in steady-state hypoxia and HVR (r = .002, p = .995, n = 12). (d) Relationship between percent change BHD from normoxia in 
hyperoxia and HVR (r = .06, p = .84, n = 12). The respective r value (Pearson correlation coefficient), P value, and n are presented on each graph
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system activation (Hagbarth & Vallbo, 1968; Lin et al., 1974; 
Steinback et  al.,  2009). These concomitant blood gas che-
mostimuli accumulate at the metabolic rate, stimulate both 
central and peripheral chemoreceptors, which continuously 
increases the drive to breathe and likely reduces BHD. Thus, 
chemoreceptor stimulation or withdrawal is contributing to 
the timing of break point during a voluntary breath hold. 
However, it is interesting that BHD did not correlate with 
HVR magnitude using a transient HVR test, which quanti-
fies the PCR sensitivity to transient reduction in arterial hy-
poxia. Thus, although chemoreceptor stimulation influences 
BHD, chemoreflex magnitude does not appear to determine 
voluntary BHD. The lack of correlation between voluntary 
apnea duration and chemoreceptor sensitivity measured as 
HVR may be a result of (a) the known variability inherent in 
transient gas perturbation tests (Pfoh et al., 2016; 2017), (b) 
the prevailing CO2 at the beginning of and throughout the BH 
and the concomitant sensitivity of the carotid bodies to CO2 
(e.g., Trembach & Zabolotskikh, 2017), and (c) the contribu-
tion of central respiratory chemoreceptors.
Few studies have assessed the relationship between che-
moreflex magnitude and BHD. Bain et  al.  (2017) showed 
that forced vital capacity (an index of lung volume) was a 
good predictor of BHD following administration of hyper-
oxia in elite apneists, but that the central chemoreflex mag-
nitude, assessed via hyperoxic rebreathing tests prior to the 
apnea, was not predictive of duration. Feiner et  al.  (1995) 
showed that the HVR was a significant predictor of BHD, 
but only when the effect of lung volume was included in sta-
tistical analysis. In addition, Feiner et al. (1995) also found 
no relationship between voluntary BHD and the central hy-
percapnic ventilatory response. Conversely, Trembach and 
Zabolotskikh (2017) found that PCR magnitude to CO2, 
tested via single breath test, was strongly, significantly, and 
inversely correlated with voluntary BHD in a large group of 
healthy participants. This is difficult to reconcile with the 
findings from our study, where the HVR not significantly 
correlated with BHD in normoxia or hypoxia, particularly 
given that we found previously that the PCR magnitude of 
HVR via transient N2 test was well correlated with the PCR 
magnitude tested via the single-breath CO2 test, within indi-
viduals (Borle et al., 2017), which was also consistent with 
a previous study (Rebuck et al. (1973). Thus, an integrative 
model of the underlying physiological and extra-physiologi-
cal mechanisms determining volitional break point remains 
to be determined.
Because voluntary apnea elicits a simultaneous blood 
gas, circulatory and neural responses that increase cere-
bral perfusion (e.g., Steinback & Poulin,  2008; Steinback 
et al., 2009; Willie et al., 2012), while limiting perfusion of 
non-vital organs (i.e., the mammalian diving reflex; Dujic 
& Breskovic,  2012; Dujic et  al.,  2013; Joulia et  al.,  2009; 
Lin, 1982), the CCRs may have played a smaller role in de-
termining break point compared to the PCRs. This mecha-
nism would theoretically dampen the CO2/H
+ stimulus to the 
CCRs by increasing cerebral blood flow and, thus, promot-
ing metabolic washout from cerebral tissues (e.g., Ainslie & 
Duffin, 2009; Bruce et al., 2016). Although cerebrovascular 
reactivity (CVR) likely dampens the role of CCR stimula-
tion on determining BHD, this conclusion is only specula-
tion without assessing a relationship between CCR and CVR 
during BHD.
4.3 | Possible Effects of CO2/[H+]
The incremental increase in CO2 during breath holding likely 
stimulates the central respiratory chemoreceptors, increasing 
the drive to breathe and likely shortening BHD (Ferris et al., 
1946). The concomitant hypercapnia during breath holding 
also plays a role in stimulating PCRs, particularly as oxy-
gen levels decrease during apnea, given that the PCRs detect 
changes in oxygen in a multiplicative, CO2/[H
+]-dependent 
fashion (e.g., Fitzgerald & Parks,  1971; Kiwull-Schone 
et al., 1976; Lahiri & DeLaney, 1975; Lahiri et al., 1978; Van 
Beek et al., 1983). In our study, these increases in CO2 may 
F I G U R E  5  Within-individual correlations between relative BHD and steady-state chemoreflex drive (SS-CD). (a) Comparison of SS-CD in 
normoxia (room air) and hypoxia (13.5%–14% O2). (b) Correlation between absolute BHD and SS-CD in normoxia (r = −.05, p = .85, n = 16). 
(c) Correlation between absolute BHD and SS-CD in hypoxia (r = .11, p = .69, n = 16). NSD, no significant difference (p > .05). The respective r 
value (Pearson correlation coefficient), p value, and n are presented on each graph
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confound our results in two possible ways: (a) the metabolic 
rate (i.e., CO2 accumulation) may have been different during 
the three BH trials, (b) hypoxia-induced lactic acid accumu-
lation may alter hypoxic sensitivity, and (c) the baseline (i.e., 
prior to breath holding) PETCO2 may have been different 
between conditions. The mean metabolic rate (i.e., V̇CO2) 
was only slightly (but significantly) higher (~7%) after 30-
min hypoxia, which likely played a limited role in increas-
ing CO2 during breath holding under hypoxic conditions. In 
addition, 30 min of hypoxia may have generated increased 
blood lactate, contributing to arterial acidosis, which we did 
not measure. However, Ainslie et al. (2014) showed that fol-
lowing 15-min steady-state hypoxia at levels similar to our 
study (PETO2 ~ 42 Torr, SaO2 ~ 78%), arterial lactate was not 
increased statistically, however, it was significantly elevated 
at more extreme hypoxia (PaO2 ~ 36 Torr, SaO2 ~ 70%; 0.6 
to 0.7 mmol/L). With respect to more chronic hypoxia, Smith 
et al. (2014) showed that on days 4–6 at 5,050 m following 
9 days of incremental ascent (PaO2 ~ 42 Torr, SaO2 ~ 81%), 
arterial lactate was only mildly but statistically elevated (0.7 
at baseline to 0.9  mmol/L). Conversely, baseline PETCO2 
was lower in hypoxia by approximately 2 Torr (see Table 1), 
which was caused by and subsequently inhibited the HVR 
(i.e., poikilocapnic hypoxia; e.g., Steinback & Poulin, 2007; 
see Table  1). Indeed, ventilation was statistically higher at 
baseline after 30 min of hypoxia, but only by approximately 
1 L/min on average. Thus, participants had higher ventilation 
in hypoxia, but it was blunted by the relative concomitant hy-
pocapnia. These two antagonistic factors, where V̇CO2 was 
higher but starting CO2 was lower compared to the normoxic 
BH, (a) are likely negligible in their contribution to BHD and 
(b) likely cancel each other out across the breath hold, leav-
ing the effects of prior oxygenation as the key variable driv-
ing differences in BHD in our study. Indeed, this complex 
interplay in generating a new steady state in the face of antag-
onistic stimuli was in part the initial justification for develop-
ing and applying our SS-CD metric (see Bruce et al., 2018; 
Leacy et al., 2020; Pfoh et al., 2017).
4.4 | BHD and SS-CD
We developed a metric of SS-CD, which encompasses the 
ventilatory strategy employed in response to the prevailing 
CO2 and O2 in the steady state (Pfoh et  al.,  2017). SS-CD 
was not different between room air and steady-state hypoxia, 
likely due to the fact that PETCO2 and SpO2 both decreased 
a similar magnitude, while ventilation was only minimally 
increased (~1  L/min) compared to room air values once 
steady state was reached in hypoxia (see Table 1). Our re-
sults suggest that the SS-CD does not determine BHD when 
compared in room air and normobaric steady-state hypoxia. 
Although we found no correlations between BHD and SS-CD 
magnitude in either acute normoxia or hypoxia, there may be 
merit in assessing the relationship between BHD and SS-CD 
during chronic hypoxic conditions (i.e., high altitude), where 
hypobaric hypoxia decreases voluntary breath hold duration 
(e.g., Ferris et al., 1946) and ventilatory acclimatization in-
creases SS-CD (e.g., Bruce et al., 2018; Leacy et al., 2020). 
However, it is possible that the temporal domain of breath 
holding (i.e., acute dynamic chemostimulation) and calcu-
lating the SS-CD (i.e., obtained during steady state) may be 
unrelated. In other words, ventilatory chemoresponses to dy-
namic and incremental changes in blood gases (both CO2 and 
O2) may be more relevant to driving voluntary BHD.
4.5 | Potential Contribution of Extra-
Chemoreceptor Factors
Despite the clear contribution of initial oxygen status on vol-
untary BHD demonstrated by this and other studies, neither 
the transient HVR nor SS-CD was significantly correlated 
with BHD. Thus, despite stimulation of central and periph-
eral respiratory chemoreceptors before and during the breath 
hold, chemoreflex magnitude does not appear to determine 
voluntary BHD, implicating extra-chemoreceptor factors. 
Previous studies demonstrated that sensitivity of the carotid 
body is not solely responsible for apnea break point, as in-
dividuals following carotid body denervation still voluntar-
ily terminated a breath hold (Davidson et al., 1974). In one 
of the most striking examples of extra-chemoreceptor con-
tributions, Campbell et  al.  (1966), Campbell et  al.  (1967), 
Campbell et al. (1969), showed that voluntary BHD was in-
creased by two to threefold in two participants following full 
paralyzation (aside from an upper arm), where participants 
indicated their volitional break point with a hand signal from 
the unanesthetized hand. These authors suggested that a por-
tion of the distressing sensations elicited by breath holding 
arise through the elimination of respiratory muscle contrac-
tion and related inhibitory afferent feedback on the drive to 
breath (Campbell et  al.,  1967). Indeed, Fowler, 1954; later 
confirmed by Flume et al., 1994) showed that if participants 
rebreathed from a bag containing hypoxic and hypercapnic 
air at break point, they could continue breath holding, despite 
no change in blood gases, illustrating that the act of breathing 
itself relieves the symptoms of distress associated with breath 
holding, at least initially. However, as the successive break 
point–rebreathing cycle continues, the BHD shortens, illus-
trating a role for chemoreceptor stimulation in the sensation 
of breathlessness and voluntary BHD.
In addition to prior oxygenation and afferent feed-
back from contracting respiratory muscles, other factors 
contribute to BHD, such as the initial lung volume (e.g., 
Feiner et al., 1995; Godfrey & Campbell, 1968; 1969; Guz 
et  al.,  1966) and volitional factors (Parkes, 2006). In our 
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study, we coached participants to initiate the breath hold at 
the end of a normal inspiration, where lung volume at the 
onset of each apnea was not equivalent between conditions 
(e.g., smaller tidal volumes during normoxia compared to 
hypoxia; see Table  1). However, given the difference be-
tween measured tidal volume was  ~  100ml between nor-
moxia and hypoxia, these differences likely contributed 
little to BHD in comparison to the measured differences in 
FIO2. Lastly, performing an additional motor or cognitive 
task (Alpher et al., 1986) as well as the simple act of train-
ing (Engan et  al.,  2013) can prolong BHD. The potential 
effects of training and volition were controlled for in our 
study by selecting untrained participants, and providing no 
encouragement to the participants throughout their apnea. 
Unfortunately, the effect of training somewhat difficult to 
control for when multiple breath holds are required for data 
collection, as participants can often breath hold for lon-
ger durations with subsequent apneas in the same session 
(unpublished observations). Taken together, these consid-
erations demonstrate that breathing holding is a complex 
physiological stressor, with multiple factors contribution to 
the ability of participants to voluntarily resist one of our 
most primitive and immediate physiological drives (e.g., 
Parkes, 2006).
4.6 | Possible Relationship to Sleep Apnea
Central and obstructive sleep apnea are comprised of re-
peated cycles with alternating phases of breath holding and 
hyperventilation during sleep (Douglas et  al.,  1982; Sin 
et  al.,  2015). Previous experimental and modeling studies 
demonstrated a relationship between chemoreflex respon-
siveness (i.e., gain) and the severity of central sleep apnea, 
particularly with ventilatory acclimatization to high altitude 
(Ainslie et al., 2013). Because of the differences in tempo-
ral delay in stimulating peripheral (short) and central (long) 
chemoreceptors (e.g., Pederson et al., 1999), it is likely that 
peripheral chemoreceptors play a more important role in 
determining the apnea–hyperventilation cycle lengths. In 
addition, the transient chemoreflex tests utilized to assess 
HVR or HCVR are similar to the kind of chemostimuation 
sleep apnea patients’ experience (i.e., short duration chem-
ostimulation). However, perhaps combining transient hy-
poxia and hypercapnia into a single transient test may be a 
more relevant “real world” stimulus. Conversely, although a 
strength of the SS-CD metric is that it takes into account the 
ventilatory strategy employed in response to the prevailing 
CO2 and O2 in the steady state, that this metric is not in fact 
a measure of gain (responsiveness) to a perturbation in the 
way the hyperventilation following an apneic event is, may 
explain the lack of a relationship between SS-CD magni-
tude and BHD in either normoxia and hypoxia. Using the 
appropriate test to assess chemoreflex gain when assessing 
its relationship to the severity of sleep apnea remains an im-
portant and evolving question (e.g., Messineo et al., 2018; 
Solin et al., 2000).
5 |  CONCLUSION
We assessed the relationship between varying levels of in-
spired oxygen and voluntary BHD in a laboratory setting, 
and assessed the possible relationships between both prior 
inspired oxygen (i.e., hypoxia, normoxia, and hyperoxia) and 
SS-CD on voluntary BHD. We found that BHD was posi-
tively related to prior oxygen status, shorter in hypoxia and 
longer in hyperoxia. However, BHD was not related to (a) 
transient HVR or (b) SS-CD, a metric combining all chem-
ostimuli in the steady state. We conclude that voluntary BHD 
is oxygen dependent, likely through PCR activation, but that 
extra-chemoreflex factors determine BHD in untrained indi-
viduals, such as lung volume, lung stretch, and volition.
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